PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Cardiothoracic Surgery, University of Utah School of Medicine, 3C 127, 30 N 1900 E, Salt Lake City, UT, 84132, USA. craig.selzman@hsc.utah.edu.\', \'Division of Cardiothoracic Surgery, University of Utah School of Medicine, 3C 127, 30 N 1900 E, Salt Lake City, UT, 84132, USA.\', \'Cell Therapy and Regenerative Medicine Program, University of Utah School of Medicine, Salt Lake City, UT, USA.\', \'Division of General Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.\', \'Pulmonary and Criticial Care Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.\', \'Division of Hematology, University of Utah School of Medicine, Salt Lake City, UT, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13104-021-05443-9
?:doi
?:hasPublicationType
?:journal
  • BMC research notes
is ?:pmid of
?:pmid
?:pmid
  • 33482902
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.691
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • A pilot trial of human amniotic fluid for the treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all